China cosmetics electronic-label pilot: A retail SKU needs both a scannable page and physical essentials

Date:

Share post:

Information date: 3 September 2026 — China’s cosmetics electronic-label pilot does not turn a QR code into a blank-package exemption. Participating businesses must align the digital page, physical essentials, filing record, packaging position and consumer access before treating a SKU as pilot-ready.

Verified facts and scope

NMPA requirements say the pilot started on 1 February 2026 in Beijing, Shanghai, Zhejiang, Shandong, Guangdong and Chongqing. The electronic label must display mandatory content directly after scanning without pop-ups or extra access conditions.

The QR code is generally at least 9 mm by 9 mm and placed prominently. The visible physical package still carries specified essentials such as Chinese product name, registration information where applicable, filer or registrant, net content, shelf life and required warnings.

How the effect reaches operations

A technically working code can still fail if the digital content differs from the filed label.

Small packaging creates space pressure but does not justify deleting required information outside stated exceptions.

Retail, warehouse and after-sales teams need a stable page even after a batch leaves production.

Decision

Use the pilot only when the company and product are eligible and the digital-label system can preserve availability, version control and filed consistency. If the physical pack, QR destination or filing platform cannot be synchronized, keep the full conventional label.

Implementation checklist

  1. Confirm pilot region, participating entity and product eligibility with the responsible authority.
  2. Build a field-level comparison of filed content, electronic page and physical package.
  3. Test QR size, print contrast, adhesion, scanning angle and common phone applications.
  4. Remove pop-ups, login gates and marketing overlays from the mandatory label page.
  5. Archive the page version and package image for each batch.
  6. Run a retail scan and consumer-information test before commercial distribution.

Evidence and review

For “China cosmetics electronic-label pilot: A retail SKU needs both a scannable page and physical essentials”, start with one real case rather than an abstract checklist. Record the input version, responsible owner, start time, observed result and stop condition. If the team cannot complete “Confirm pilot region, participating entity and product eligibility with the responsible authority.” with current evidence, it should not expand the process to more products, patients, suppliers or markets. The first review should focus only on facts capable of changing the decision.

The second control follows “Build a field-level comparison of filed content, electronic page and physical package.”. Keep the source date, applicable population or entity, deadline, cost effect and owner in the same evidence file. A wording preference does not justify a new version. A repeated discrepancy, an unsupported health claim or a regulatory mismatch does: correct that point and hold release until the evidence is available.

After “Test QR size, print contrast, adhesion, scanning angle and common phone applications.”, compare the intended outcome with what actually happened. Apply the same success criteria to each later expansion. If only one number, date or responsibility changes, update that field and the affected conclusion instead of recreating evidence that remains valid. This keeps the decision traceable without turning review into an open-ended rewrite cycle.

Release criterion

The release test for “China cosmetics electronic-label pilot: A retail SKU needs both a scannable page and physical essentials” is not document volume. Each material number needs a date and denominator, each action needs an owner and trigger, and each exception needs an escalation route. When the source, operating step and limit align, minor wording differences do not justify another rewrite. If the conclusion still depends on an unverified assumption, narrow the claim or pause the affected decision until direct evidence is available.

Counter-scenario and ownership

The review must also test the opposite of the expected outcome. If “A technically working code can still fail if the digital content differs from the filed label.”, the record should already identify who detects it, who can pause the process, and who communicates with affected people or authorities. Direct, current evidence about the studied product, population or transaction takes priority when it conflicts with a broad market statement. Keep both the approval reason and the rejection reason. Later evidence should reopen only the affected question, not trigger an unsupported rewrite of findings that still hold.

Limits of the conclusion

This is an operational reading of published pilot requirements, not approval for a specific cosmetic. Children’s cosmetics, toothpaste, special cosmetics and small packages may need additional treatment. Verify the current Chinese rules.

Primary sources

Related articles

China’s August policy roundup for foreign companies: Build an owner-and-deadline matrix

Information date: 3 September 2026 — The State Council’s 1 September roundup groups August policies relevant to expatriates and foreign enterprises. The practical task is not to circulate the page internally; it is to id

China August manufacturing PMI reached 49.8: Use orders and company size before changing inventory

Information date: 3 September 2026 — China’s official manufacturing PMI rose 0.6 points to 49.8 in August 2026. New orders reached 50.6 and production 50.4, while medium and small enterprises remained below 50. The relea

China foreign-investment action plan: Convert opening measures into a province-and-license test

Information date: 3 September 2026 — China’s 2026 action plan for stabilising and optimising foreign investment describes wider service-sector pilots, investment promotion and fair-competition work. A company should not

China medical-device classification guide: Intended purpose comes before the product brochure

Information date: 3 September 2026 — China divides medical devices into Classes I, II and III by risk. A foreign manufacturer should not start from a competitor’s product card; it should define intended purpose, structur